Pulse oximeter and sensor optimized for low saturation

• US 7,349,726 B2
• Filed: 04/19/2006
• Issued: 03/25/2008
• Est. Priority Date: 04/01/1994
• Status: Expired due to Fees

• Current Assignee: Nellcor Puritan Bennett LLC (Medtronic Plc)
• Original Assignee: Nellcor Puritan Bennett LLC (Medtronic Plc)
• Inventors: Mannheimer, Paul D., Nierlich, Steve L., Casciani, James R., Ruskewicz, Stephen J.
• Primary Examiner(s): WINAKUR, ERIC FRANK
• Application Number:
  US11/407,771
• Publication Number:
  US 20060189862A1
• Time in Patent Office: 706 Days
• Field of Search: 600/309, 600/310, 600/313, 600/322, 600/323, 600/338
• US Class Current: 600/338
• CPC Class Codes: A61B 2562/0242 for varying or adjusting the optical path length in the tissue
• CPC Class Codes: A61B 5/14542 for measuring blood gases A61B5/14551 takes precedence
• CPC Class Codes: A61B 5/1464 specially adapted for foetal tissue
• CPC Class Codes: A61B 5/7207 of noise induced by motion artifacts

Abstract

Embodiments of the present invention are directed to a system and method for measuring blood oxygen saturation. Specifically, embodiments of the present invention include emitting light having a wavelength spectrum that is optimized for an oxygen saturation reading less than 80 percent, detecting the light, and transmitting signals based on the detected light, the signals being useful in determining blood oxygen saturation with a pulse oximeter.

Claims

1. A method for measuring blood oxygen saturation, comprising:

emitting light from a light source of a pulse oximeter sensor;

detecting the light at a detector of the pulse oximeter sensor;

limiting light signals received at the detector from the light source to two or less spectra, wherein the two or less spectra are optimized for an oxygen saturation reading less than 80 percent;

transmitting signals based on the limited light to a pulse oximeter, the signals being useful in determining blood oxygen saturation with the pulse oximeter; and

calculating a blood oxygen saturation value based on the limited light.

2. The method of claim 1, wherein the two or less spectra are optimized for a fetal oxygen saturation reading.

3. The method of claim 1, wherein the two or less spectra are optimized for an oxygen saturation reading less than 65 percent.

4. The method of claim 1, wherein the two or less spectra are optimized for an oxygen saturation reading greater than 15 percent.

5. The method of claim 1, comprising detecting the light with the detector, wherein the detector is located a distance of at least 10 mm from the light source that is emitting the light.

6. The method of claim 1, comprising emitting the light a distance from the detector, wherein the distance is optimized to reduce a sensitivity to perturbation induced artifacts in determining the blood oxygen saturation.

7. The method of claim 1, comprising emitting both red and an infrared light, wherein the infrared light has an infrared wavelength in a range useful for adults and the red light has a red wavelength in a range optimized for a fetus.

8. The method of claim 7, wherein the range optimized for the fetus of the red wavelength includes 735 nanometers at an intensity of at least 50% of an intensity of any other wavelengths in the wavelength spectrum.

9. The method of claim 1, wherein a mean wavelength of one of the two or less spectra is between about 700 and about 790 nanometers.

10. The method of claim 9, wherein a mean wavelength of one of the two or less spectra is 805 nanometers to 940 nanometers.

11. The method of claim 1, wherein the two or less spectra are optimized for increased depth of penetration of light in a fetus as compared to an optimum penetration depth for an adult.

12. The method of claim 1, wherein the light comprises red light and infrared light, each of the red light and infrared light having an extinction and scattering coefficient for blood perfused tissue, wherein the two or less spectra are optimized such that a product of the extinction and scattering coefficients of the red light and the infrared light forms first and second values, a ratio between the first and second values being between 0.5 and 2.0 for a majority of an oxygen saturation reading range of 0 to 65 percent.

13. The method of claim 1, wherein the two or less spectra are optimized such that sensitivity to perturbation induced artifacts and changes in saturation are limited in determining blood oxygen saturation with the pulse oximeter.

14. A pulse oximeter sensor for measuring blood oxygen saturation, comprising:

a light emitter configured to emit light;

a light detector configured to detect the light and to transmit signals based on the detected light, the signals being useful in determining blood oxygen saturation with a pulse oximeter; and

a limiting component configured to limit light signals received at the detector from the light source to two or less spectra, wherein the two or less spectra are optimized for an oxygen saturation reading less than 80 percent.

15. The sensor of claim 14, wherein the light emitter is optimized such that the two or less spectra are optimized for a fetal oxygen saturation reading.

16. The sensor of claim 14, wherein the light emitter is optimized such that the two or less spectra are optimized for an oxygen saturation reading less than 65 percent.

17. The sensor of claim 14, wherein the light emitter is optimized such that the two or less spectra are optimized for an oxygen saturation reading greater than 15 percent.

18. The sensor of claim 14, wherein the light detector is located a distance of at least 10 mm from the light emitter.

19. The sensor of claim 14, wherein a distance between the light emitter and light detector is optimized to reduce a sensitivity to perturbation induced artifacts in determining the blood oxygen saturation.

20. The sensor of claim 14, wherein the light emitter comprises a red light emitter and an infrared light emitter, wherein the infrared light emitter emits light having an infrared wavelength in a range useful for adults and the red light emitter emits light having a red wavelength in a range optimized for a fetus.

21. The sensor of claim 20, wherein the range optimized for the fetus of the red wavelength includes 735 nanometers at an intensity of at least 50% of an intensity of any other wavelengths in the wavelength spectrum.

22. The sensor of claim 14, wherein a mean wavelength of one of the two or less spectra is between about 700 and about 790 nanometers.

23. The sensor of claim 22, wherein a mean wavelength of one of the two or less spectra is 805 nanometers to 940 nanometers.

24. The sensor of claim 14, wherein the light emitter comprises a red light emitter and an infrared light emitter, each of the red and infrared light emitters configured to emit light having an extinction and scattering coefficient for blood perfused tissue, wherein the two or less spectra are optimized such that a product of the extinction and scattering coefficients of the red and infrared lights forms first and second values, a ratio between the first and second values being between 0.5 and 2.0 for a majority of an oxygen saturation reading range of 0 to 65 percent.

25. The sensor of claim 14, wherein the light emitter is optimized such that the two or less spectra are optimized to limit sensitivity to perturbation induced artifacts and changes in saturation in determining blood oxygen saturation with the pulse oximeter.

26. A method of manufacturing a pulse oximeter sensor for measuring blood oxygen saturation, comprising:

providing a light emitter configured to emit light;

providing a light detector configured to detect the light and to transmit signals based on the detected light, the signals being useful in determining blood oxygen saturation with a pulse oximeter sensor; and

disposing a limiting component within the pulse oximeter sensor, the limiting component configured to limit light signals received at the detector from the light source to two or less spectra, wherein the two or less spectra are optimized for an oxygen saturation reading less than 80 percent.

27. The method of claim 26, wherein a mean wavelength of one of the two or less spectra is 805 nanometers to 940 nanometers.

28. The method of claim 27, wherein a mean wavelength of one of the two or less spectra is 700 nanometers to 790 nanometers.

29. A pulse oximeter system, comprising:

a pulse oximeter configured to read signal data and derive patient physiological data from the signal data; and

a sensor comprising;

a light emitter configured to emit light;

a light detector configured to detect the light and to transmit signals based on the detected light, the signals comprising the signal data being useful in determining blood oxygen saturation with the pulse oximeter; and

a limiting component configured to limit light signals received at the detector from the light source to two or less spectra, wherein the two or less spectra are optimized for an oxygen saturation reading less than 80 percent.

30. The system of claim 29, wherein a mean wavelength of one of the two or less spectra is 805 nanometers to 940 nanometers.

31. The system of claim 30, wherein a mean wavelength of one of the two or less spectra is 700 nanometers to 790 nanometers.